CMRA logo

CMRA Stock Overview

Profile

Full Name:

Comera Life Sciences Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 21, 2020

Indexes:

Not included

Website:

http://comeralifesciences.com

Description:

Comera Life Sciences Holdings focuses on developing innovative drug delivery solutions. The company aims to enhance the effectiveness of biologic therapies, making them easier to administer and improving patient outcomes. Their technology targets various medical conditions, offering potential advancements in treatment options.

Key Details

Price

$0.00

Market Cap

$6147.56(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$633.10 K(+97.97% YoY)

Annual EPS

-$1.76(-516.25% YoY)

PE Ratio

-

Annual ROE

288.20%

Annual Debt To Equity

-0.07

Beta

31.81

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 16, 2023

Recent annual earnings:

Mar 16, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with CMRA included

Stocks cheaper than 1 dollar
US stocks
Stocks with high beta
Stocks below SMA 200
Best performing stocks last 3 months
Healthcare sector
All stocks
NASDAQ Listed Companies
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.00
CMRA price is $0.00

Price All-time High

$14.25
CMRA price is currently -100.00% below its historical high of $14.25

Price Analysts Target

-
CMRA price consensus analysts' forecast is unknown

Price Most Recent Change

0%
CMRA {parameterFullLabel} has remained unchanged on Mar 7, 2025

Price YTD Change

0%
CMRA {parameterFullLabel} has remained unchanged since January 1st

Price 3-Year Change

-100%
CMRA price is down -100% over the past 3 years

Market cap

Market Cap

$6147.56
CMRA market capitalization is $6147.56

Market Cap 3-Year Change

-
CMRA market capitalization 3-year change is unknown

Market Cap All-time High

$168.92 M
CMRA market capitalization is currently -100.00% below its historical high of $168.92 million

Market Cap Sector Rank

1.48%
CMRA market capitalization is higher than 1.48% of companies in Healthcare sector

Technical

Beta

31.81
CMRA beta is 31.81

200-day SMA

$0.01
CMRA price is currently -98.33% below its 200-day simple moving average

14-day RSI

50.00
CMRA 14-day relative strength index is 50.00

30-day Relative Volume

0.28
CMRA 30-day relative volume is 0.28

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$633.10 K
CMRA annual revenue is $633.10 thousand

Annual Revenue Analysts Estimate

-
CMRA annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

+97.97%
CMRA annual revenue is up +97.97% year-on-year

Annual Revenue Sector Rank

10.19%
CMRA annual revenue is higher than 10.19% of companies in Healthcare sector

Profit

Annual Gross Profit

$422.70 K
CMRA annual gross profit is $422.70 thousand

Annual Gross Margin

66.77%
CMRA annual gross profit margin is 66.77%

Annual Operating Profit

-$11.97 M
CMRA annual operating income is -$11.97 million

Annual Operating Margin

-1890.69%
CMRA annual operating profit margin is -1890.69%

Annual Net Income

-$18.00 M
CMRA annual net profit is -$18.00 million

Annual Net Margin

-2843.79%
CMRA annual net profit margin is -2843.79%

EPS

Annual EPS

-$1.76
CMRA annual earnings per share is -$1.76

Annual EPS Analysts Estimate

-
CMRA annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-516.25%
CMRA annual earnings per share is down -516.25% year-on-year

Annual EPS Sector Rank

44.95%
CMRA annual earnings per share is higher than 44.95% of companies in Healthcare sector

ROA & ROE

Annual ROA

-323.09%
CMRA annual return on assets is -323.09%

Annual ROE

288.20%
CMRA annual return on equity is 288.20%

EBIT & EBITDA

Annual EBIT

-$17.98 M
CMRA annual earnings before interest & taxes is -$17.98 million

Annual EBITDA

-$17.89 M
CMRA annual EBITDA is -$17.89 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CMRA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CMRA price to earnings ratio is unknown

PB Ratio

PB Ratio

0.00
CMRA price to book ratio is 0.00

PB Ratio Sector Rank

15.98%
CMRA price to book ratio is higher than 15.98% of companies in Healthcare sector

PS Ratio

PS Ratio

0.01
CMRA price to sales ratio is 0.01

PS Ratio Sector Rank

2.09%
CMRA price to sales ratio is higher than 2.09% of companies in Healthcare sector

Enterprise value

Enterprise Value

-$1.59 M
CMRA enterprise value is -$1.59 million

Enterprise Value Sector Rank

9.13%
CMRA enterprise value is higher than 9.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.18
CMRA EV/EBITDA is 0.18

EV/EBITDA Sector Rank

69.35%
CMRA EV/EBITDA is higher than 69.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.61
CMRA annual current ratio is 0.61

Annual Quick Ratio

-
CMRA annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.07
CMRA annual debt to equity ratio is -0.07

Annual Interest Coverage Ratio

-881.55
CMRA annual interest coverage ratio is -881.55

Risk & Stability

Piotroski F-Score

3
CMRA piotroski f-score is 3

Altman Z-Score

-29.51
CMRA altman z-score is -29.51

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$3.73 M
CMRA annual total assets is $3.73 million

Annual Non Current Assets

$664.00 K
CMRA annual long term assets is $664.00 thousand

Annual Current Assets

$3.06 M
CMRA annual total current assets is $3.06 million

Annual Cash & Cash Equivalents

$446.60 K
CMRA annual cash & cash equivalents is $446.60 thousand

Equity

Annual Book Value

-$6.25 M
CMRA annual book value is -$6.25 million

Annual Working Capital

-$2.00 M
CMRA annual working capital is -$2.00 million

Liabilities

Annual Total Liabilities

$9.97 M
CMRA annual total liabilities is $9.97 million

Annual Total Long Term Liabilities

$4.92 M
CMRA annual total long term liabilities is $4.92 million

Annual Current Liabilities

$5.06 M
CMRA annual total current liabilities is $5.06 million

Annual Accounts Payable

$1.46 M
CMRA annual accounts payable is $1.46 million

Debt

Annual Total Debt

$775.00 K
CMRA annual total debt is $775.00 thousand

Annual Total Debt 1-Year Change

+139.86%
CMRA annual total debt is up +139.86% year-on-year

Annual Long Term Debt

$120.30 K
CMRA annual long term debt is $120.30 thousand

Annual Short Term Debt

$654.70 K
CMRA annual short term debt is $654.70 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$12.60 M
CMRA annual total expenses is $12.60 million

Annual Operating Expenses

$12.39 M
CMRA annual total operating expenses is $12.39 million

Annual Cost Of Goods Sold

$210.40 K
CMRA annual cost of goods sold is $210.40 thousand

Annual SGA

$10.65 M
CMRA annual SGA is $10.65 million

Annual D&A

$93.90 K
CMRA annual depreciation & amortization is $93.90 thousand

Annual Interest Expense

$20.40 K
CMRA annual interest expense is $20.40 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$9.77 M
CMRA annual cash flow from operations is -$9.77 million

Annual CFO 1-Year Change

-160.03%
CMRA annual cash flow from operations is down -160.03% year-on-year

Annual CFI

-$28.60 K
CMRA annual cash flow from investing activities is -$28.60 thousand

Annual CFI 1-Year Change

+79.86%
CMRA annual cash flow from investing activities is up +79.86% year-on-year

Annual CFF

$5.24 M
CMRA annual cash flow from financing activities is $5.24 million

Annual CFF 1-Year Change

-49%
CMRA annual cash flow from financing activities is down -49% year-on-year

Free CashFlow

Annual FCF

-$9.80 M
CMRA annual free cash flow is -$9.80 million

Annual FCF 1-Year Change

-151.29%
CMRA annual free cash flow is down -151.29% year-on-year

CAPEX

Annual CAPEX

$28.60 K
CMRA annual capital expenditures is $28.60 thousand

Annual CAPEX 1-Year Change

-79.86%
CMRA annual capital expenditures is down -79.86% year-on-year

Institutional Ownership

Similar stocks

NMRD logo
Nemaura Medical (NMRD)
STAB logo
Statera Biopharma (STAB)
ARDS logo
Aridis Pharmaceuticals (ARDS)
MTEM logo
Molecular Templates (MTEM)
CALA logo
Calithera Biosciences (CALA)
EVLO logo
Evelo Biosciences (EVLO)
BTTX logo
Better Therapeutics (BTTX)
THMO logo
ThermoGenesis Holdings (THMO)
AMPE logo
Ampio Pharmaceuticals (AMPE)

FAQ

  • What is the ticker symbol for Comera Life Sciences Holdings?
  • Does Comera Life Sciences Holdings pay dividends?
  • What sector is Comera Life Sciences Holdings in?
  • What industry is Comera Life Sciences Holdings in?
  • What country is Comera Life Sciences Holdings based in?
  • When did Comera Life Sciences Holdings go public?
  • Is Comera Life Sciences Holdings in the S&P 500?
  • Is Comera Life Sciences Holdings in the NASDAQ 100?
  • Is Comera Life Sciences Holdings in the Dow Jones?
  • When was Comera Life Sciences Holdings's last earnings report?
  • When does Comera Life Sciences Holdings report earnings?

What is the ticker symbol for Comera Life Sciences Holdings?

The ticker symbol for Comera Life Sciences Holdings is NASDAQ:CMRA

Does Comera Life Sciences Holdings pay dividends?

No, Comera Life Sciences Holdings does not pay dividends

What sector is Comera Life Sciences Holdings in?

Comera Life Sciences Holdings is in the Healthcare sector

What industry is Comera Life Sciences Holdings in?

Comera Life Sciences Holdings is in the Biotechnology industry

What country is Comera Life Sciences Holdings based in?

Comera Life Sciences Holdings is headquartered in United States

When did Comera Life Sciences Holdings go public?

Comera Life Sciences Holdings's initial public offering (IPO) was on December 21, 2020

Is Comera Life Sciences Holdings in the S&P 500?

No, Comera Life Sciences Holdings is not included in the S&P 500 index

Is Comera Life Sciences Holdings in the NASDAQ 100?

No, Comera Life Sciences Holdings is not included in the NASDAQ 100 index

Is Comera Life Sciences Holdings in the Dow Jones?

No, Comera Life Sciences Holdings is not included in the Dow Jones index

When was Comera Life Sciences Holdings's last earnings report?

Comera Life Sciences Holdings's most recent earnings report was on Mar 16, 2023

When does Comera Life Sciences Holdings report earnings?

The date for Comera Life Sciences Holdings's next earnings report has not been announced yet